Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOUNCE THERAPEUTICS, INC.

(JNCE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart JOUNCE THERAPEUTICS, INC.
Upcoming events on JOUNCE THERAPEUTICS, INC.
11/16/21 Q3 2021 Earnings Release (Projected)
03/10/22 FY 2021 Earnings Release (Projected)
05/11/22 Q1 2022 Earnings Release (Projected)
08/10/22 Interim 2022 Earnings Release (Projected)
Past events on JOUNCE THERAPEUTICS, INC.
09/29/21 | 04:00pm Cantor Fitzgerald Global Healthcare Conference
09/15/21 | 12:15pm Baird Global Healthcare Conference
09/13/21 | 07:00am H.C. Wainwright Global Investment Conference
09/10/21 | 08:00am Wells Fargo Virtual Healthcare Conference
08/05/21 | 08:00am Interim 2021 Earnings Call
08/05/21 | 07:00am Interim 2021 Earnings Release
07/14/21 | 04:20pm William Blair Biotech Focus Conference
06/23/21 | 10:00am R&D Day
06/21/21 | 12:40pm Raymond James Human Health Innovations Conference
06/18/21 | 09:00am Annual General Meeting
Past dividends on JOUNCE THERAPEUTICS, INC.

- No events available -

Annual results
Fiscal Period : December201620172018201920202021
Sales
M $
Released
Forecast
Spread
37,2
32,7
14%
71,6
73,7
-2,8%
65,2
57,7
13%
148
158
-6,4%
62,3
33,7
85%
 
45,7
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-12,5
-19,8
37%


 
-27,5
-33,0
17%
56,7
62,4
-9,2%


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-14,5
-17,7
18%
-19,2
-19,9
3,5%
-31,3
-40,3
22%
52,8
62,8
-16%
-45,1
-65,7
31%
 
-70,9
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-13,7
-18,5
26%
-16,4
-17,4
5,8%
-27,3
-36,4
25%
56,9
67,0
-15%
-43,8
-64,0
32%
 
-70,1
 
Net income
M $
Released
Forecast
Spread
-13,7
-18,3
25%
-17,2
-19,5
12%
-27,4
-36,4
25%
56,8
66,9
-15%
-43,8
-64,1
32%
 
-69,4
 
EPS
$
Released
Forecast
Spread
-11,0
-2,06
-435%
-0,57
-0,60
4,7%
-0,84
-1,13
26%
1,66
2,04
-19%
-1,24
-1,99
38%
 
-1,41
 
Announcement Date03/10/201703/08/201803/06/201902/27/202002/25/2021-
Quarterly results
Fiscal Period : December2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
Sales
M $
Released
Forecast
Spread


 

15,9
 
62,3
33,7
85%
1,54
11,8
-87%
25,4
8,16
211%
 
6,48
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-27,4
-21,5
-27%


 


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-28,2
-24,5
-15%
-25,1
-10,5
-139%
35,4
14,8
140%
-26,5
-25,3
-5,1%
-4,05
-20,6
80%
 
-22,6
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-28,0
-23,8
-17%
-24,9
-9,71
-156%
35,5
23,4
51%
-26,5
-24,9
-6,7%
-4,01
-20,1
80%
 
-22,2
 
Net income
M $
Released
Forecast
Spread
-28,0
-23,8
-17%
-24,9
-9,71
-156%
35,5
15,2
133%
-26,5
-24,9
-6,7%
-4,01
-19,2
79%
 
-22,2
 
EPS
$
Released
Forecast
Spread
-0,82
-0,73
-12%
-0,73
-0,45
-64%
0,86
0,22
296%
-0,58
-0,59
1,7%
-0,08
-0,36
78%
 
-0,44
 
Announcement Date08/07/202011/06/202002/25/202105/04/202108/05/2021-
Previous year Next Year
Upcoming sector events for JOUNCE THERAPEUTICS, INC.
More events
Past sector events for JOUNCE THERAPEUTICS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise